Plasma antibodies to oral bacteria and risk of pancreatic cancer in a large European prospective cohort study

Gut

Volumn 62, Issue 12, 2013, Pages 1764-1770

  Michaud, Dominique S ^a,b   Izard, Jacques ^c,d   Wilhelm Benartzi, Charlotte S ^b   You, Doo Ho ^c   Grote, Verena A ^e   Tjønneland, Anne ^f   Dahm, Christina C ^g,h   Overvad, Kim ^g   Jenab, Mazda ⁱ   Fedirko, Veronika ⁱ   Boutron Ruault, Marie Christine ^j,k   Clavel Chapelon, Françoise ^j,k   Racine, Antoine ^j,k   Kaaks, Rudolf ^e   Boeing, Heiner ^l   Foerster, Jana ^l   Trichopoulou, Antonia ^m,n   Lagiou, Pagona ^m,o,p   Trichopoulos, Dimitrios ^o,p   Sacerdote, Carlotta ^q   Sieri, Sabina ^r   Palli, Domenico ^s   Tumino, Rosario ^t   Panico, Salvatore ^u   Siersema, Peter D ^v   Peeters, Petra H M ^v   Lund, Eiliv ^w   Barricarte, Aurelio ^x,y   Huerta, José María ^y,z   Molina Montes, Esther ^y,aa   Dorronsoro, Miren ^ab   Ramon Quiros J ^ac   Duell, Eric J ^ad   Ye, Weimin ^ae,af   Sund, Malin ^af   Lindkvist, Björn ^ag   Johansen, Dorthe ^ah   Khaw, Kay Tee ^ai   Wareham, Nick ^aj   Travis, Ruth C ^ak   Vineis, Paolo ^b   Bas Bueno De Mesquita, H ^v,al   Riboli, Elio ^b   more..

^a BROWN UNIVERSITY   (United States)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c FORSYTH INSTITUTE   (United States)

^d HARVARD SCHOOL OF DENTAL MEDICINE   (United States)

^e GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^f INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^g AARHUS UNIVERSITY   (Denmark)

^h AARHUS UNIVERSITY HOSPITAL   (Denmark)

ⁱ INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^j INSTITUT GUSTAVE ROUSSY   (France)

^k UNIVERSITÉ PARIS SACLAY   (France)

^l GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^m UNIVERSITY OF ATHENS   (Greece)

ⁿ HELLENIC HEALTH FOUNDATION   (Greece)

^o HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^p BIOMEDICAL RESEARCH FOUNDATION   (Greece)

^q Human Genetics Foundation   (Italy)

^r NATIONAL CANCER INSTITUTE   (Italy)

^s CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

^t CIVILE M P AREZZO HOSPITAL   (Italy)

^u UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^v UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^w UNIVERSITY OF TROMSØ   (Norway)

^x INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^y CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^z Murcia Regional Health Authority   (Spain)

^aa ANDALUSIAN SCHOOL OF PUBLIC HEALTH   (Spain)

^ab Basque Government   (Spain)

^ac Health and Health Care Services Council   (Spain)

^ad CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^ae KAROLINSKA INSTITUTE   (Sweden)

^af UMEÅ UNIVERSITY   (Sweden)

^ag UNIVERSITY OF GOTHENBURG   (Sweden)

^ah LUND UNIVERSITY HOSPITAL   (Sweden)

^ai UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^aj MRC EPIDEMIOLOGY UNIT   (United Kingdom)

^ak UNIVERSITY OF OXFORD   (United Kingdom)

^al NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY;

ADULT; AGGREGATIBACTER ACTINOMYCETEMCOMITANS; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; BODY MASS; CANCER RISK; CASE CONTROL STUDY; COHORT ANALYSIS; COMMENSAL; CONTROLLED STUDY; DISEASE ASSOCIATION; EUROPE; FEMALE; GROWTH INHIBITION; HUMAN; MAJOR CLINICAL STUDY; MALE; MOUTH FLORA; PANCREAS CANCER; PERIODONTAL DISEASE; PORPHYROMONAS GINGIVALIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK REDUCTION; SMOKING; TANNERELLA FORSYTHENSIS;

BACTERIAL PATHOGENESIS; EPIDEMIOLOGY; PANCREATIC CANCER;

ADULT; AGED; ANTIBODIES, BACTERIAL; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; PERIODONTAL DISEASES; PORPHYROMONAS GINGIVALIS; RISK FACTORS; VEILLONELLA;

EID: 84887615482     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2012-303006     Document Type: Article

References (56)

1. American Cancer Society. Cancer facts and figures 2012 Atlanta: American Cancer Society, 2012.
2. Michaud DS, Joshipura K, Giovannucci E, et al. A prospective study of periodontal disease and pancreatic cancer in US male health professionals. J Natl Cancer Inst 2007;99:171-5.
3. Hujoel PP, Drangsholt M, Spiekerman C, et al. An exploration of the periodontitis-cancer association. Ann Epidemiol 2003;13:312-16.
4. Arora M, Weuve J, Fall K, et al. An exploration of shared genetic risk factors between periodontal disease and cancers: a prospective co-twin study. Am J Epidemiol 2010;171:253-9.
5. Stolzenberg-Solomon RZ, Dodd KW, Blaser MJ, et al. Tooth loss, pancreatic cancer, and Helicobacter pylori. Am J Clin Nutr 2003;78:176-81.
6. Nilsson HO, Stenram U, Ihse I, et al. Re: Helicobacter pylori seropositivity as a risk factor for pancreatic cancer. J Natl Cancer Inst 2002;94:632-3.
7. Trikudanathan G, Philip A, Dasanu CA, et al. Association between Helicobacter pylori infection and pancreatic cancer. A Cumulative Meta-Analysis JOP 2011;12:26-31.
8. Brook I, Frazier EH. Microbiological analysis of pancreatic abscess. Clin Infect Dis 1996;22:384-5.
9. Swidsinski A, Schlien P, Pernthaler A, et al. Bacterial biofilm within diseased pancreatic and biliary tracts. Gut 2005;54:388-95.
10. De Waele B, Delvaux G, Lauwers S. Microbiology of bile in cholelithiasis patients with and without acute pancreatitis. Pancreas 2009;38:102-3.
11. Holden JL, Berne TV, Rosoff L Sr. Pancreatic abscess following acute pancreatitis. Arch Surg 1976;111:858-61.
12. Widdison AL. Pathogenesis of pancreatic infection. Ann R Coll Surg Engl 1996;78:350-3.
13. Fritz S, Hackert T, Hartwig W, et al. Bacterial translocation and infected pancreatic necrosis in acute necrotizing pancreatitis derives from small bowel rather than from colon. Am J Surg 2010;200:111-17.
14. Seville LA, Patterson AJ, Scott KP, et al. Distribution of tetracycline and erythromycin resistance genes among human oral and fecal metagenomic DNA. Microb Drug Resist 2009;15:159-66.
15. Dal Bello F, Hertel C. Oral cavity as natural reservoir for intestinal lactobacilli. Syst Appl Microbiol 2006;29:69-76.
16. Maukonen J, Matto J, Suihko ML, et al. Intra-individual diversity and similarity of salivary and faecal microbiota. J Med Microbiol 2008;57(Pt 12):1560-8.
17. Pei Z, Bini EJ, Yang L, et al. Bacterial biota in the human distal esophagus. Proc Natl Acad Sci USA 2004;101:4250-5.
18. Farrell JJ, Zhang L, Zhou H, et al. Variations of oral microbiota are associated with pancreatic diseases including pancreatic cancer. Gut 2012;61:582-8.
19. Riboli E, Hunt KJ, Slimani N, et al. European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr 2002;5(6B):1113-24.
20. Sakellari D, Socransky SS, Dibart S, et al. Estimation of serum antibody to subgingival species using checkerboard immunoblotting. Oral Microbiol Immunol 1997;12:303-10.
21. Ebersole JL, Steffen MJ. Human antibody responses to outer envelope antigens of Porphyromonas gingivalis serotypes. J Periodontal Res 1995;30:1-14.
22. Pussinen PJ, Vilkuna-Rautiainen T, Alfthan G, et al. Multiserotype enzyme-linked immunosorbent assay as a diagnostic aid for periodontitis in large-scale studies. J Clin Microbiol 2002;40:512-18.
23. Vilkuna-Rautiainen T, Pussinen PJ, Mattila K, et al. Antigenically diverse reference strains and autologous strains of Actinobacillus actinomycetemcomitans are equally efficient antigens in enzyme-linked immunosorbent assay analysis. J Clin Microbiol 2002;40:4640-5.
24. Fraley C, Raftery AE. Model-based clustering, discriminant analysis, and density estimation. J Am Stat Assoc 2002;97:611-31.
25. Mount DW. Bioinformatics: sequence and genome analysis. 2nd edn. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 2004.
26. Vrieling A, Bueno-de-Mesquita HB, Boshuizen HC, et al. Cigarette smoking, environmental tobacco smoke exposure and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer 2010;126:2394-403.
27. Dewhirst FE, Chen T, Izard J, et al. The human oral microbiome. J Bacteriol 2010;192:5002-17.
28. Singh A, Wyant T, Anaya-Bergman C, et al. The capsule of Porphyromonas gingivalis leads to a reduction in the host inflammatory response, evasion of phagocytosis, and increase in virulence. Infect Immun 2011;79:4533-42.
29. Laine ML, Van Winkelhoff AJ. Virulence of six capsular serotypes of Porphyromonas gingivalis in a mouse model. Oral Microbiol Immunol 1998;13:322-5.
30. Sundqvist G, Figdor D, Hanstrom L, et al. Phagocytosis and virulence of different strains of Porphyromonas gingivalis. Scand J Dent Res 1991;99:117-29.
31. Lee JY, Sojar HT, Bedi GS, et al. Porphyromonas (Bacteroides) gingivalis fimbrillin: size, amino-terminal sequence, and antigenic heterogeneity. Infect Immun 1991;59:383-9.
32. Vlachojannis C, Dye BA, Herrera-Abreu M, et al. Determinants of serum IgG responses to periodontal bacteria in a nationally representative sample of US adults. J Clin Periodontol 2010;37:685-96.
33. Tanner AC, Kent RL Jr, Maiden MF, et al. Serum IgG reactivity to subgingival bacteria in initial periodontitis, gingivitis and healthy subjects. J Clin Periodontol 2000;27:473-80.
34. Ebersole JL, Taubman MA, Smith DJ, et al. Humoral immune responses and diagnosis of human periodontal disease. J Periodontal Res 1982;17:478-80.
35. Papapanou PN. Population studies of microbial ecology in periodontal health and disease. Ann Periodontol 2002;7:54-61.
36. Papapanou PN, Baelum V, Luan WM, et al. Subgingival microbiota in adult Chinese: prevalence and relation to periodontal disease progression. J Periodontol 1997;68:651-66.
37. Griffen AL, Becker MR, Lyons SR, et al. Prevalence of Porphyromonas gingivalis and periodontal health status. J Clin Microbiol 1998;36:3239-42.
38. Riep B, Edesi-Neuss L, Claessen F, et al. Are putative periodontal pathogens reliable diagnostic markers? J Clin Microbiol 2009;47:1705-11.
39. Lau L, Sanz M, Herrera D, et al. Quantitative real-time polymerase chain reaction versus culture: a comparison between two methods for the detection and quantification of Actinobacillus actinomycetemcomitans, Porphyromonas gingivalis and Tannerella forsythensis in subgingival plaque samples. J Clin Periodontol 2004;31:1061-9.
40. Huttenhower C, Gevers D, Knight R, et al. Structure, function and diversity of the healthy human microbiome. Nature 2012;486:207-14.
41. Segata N, Haake SK, Mannon P, et al. Composition of the adult digestive tract bacterial microbiome based on seven mouth surfaces, tonsils, throat and stool samples. Genome Biol 2012;13:R42.
42. Kumar PS, Leys EJ, Bryk JM, et al. Changes in periodontal health status are associated with bacterial community shifts as assessed by quantitative 16S cloning and sequencing. J Clin Microbiol 2006;44:3665-73.
43. Marsh PD. Microbial ecology of dental plaque and its significance in health and disease. Adv Dent Res 1994;8:263-71.
44. Dzink JL, Socransky SS, Haffajee AD. The predominant cultivable microbiota of active and inactive lesions of destructive periodontal diseases. J Clin Periodontol 1988;15:316-23.
45. Haffajee AD, Socransky SS, Smith C, et al. Relation of baseline microbial parameters to future periodontal attachment loss. J Clin Periodontol 1991;18:744-50.
46. Amundadottir L, Kraft P, Stolzenberg-Solomon RZ, et al. Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet 2009;41:986-90.
47. Pare G, Chasman DI, Kellogg M, et al. Novel association of ABO histo-blood group antigen with soluble ICAM-1: results of a genome-wide association study of 6, 578 women. PLoS Genet 2008;4:e1000118.
48. Paterson AD, Lopes-Virella MF, Waggott D, et al. Genome-wide association identifies the ABO blood group as a major locus associated with serum levels of soluble E-selectin. Arterioscler Thromb Vasc Biol 2009;29:1958-67.
49. Qi L, Cornelis MC, Kraft P, et al. Genetic variants in ABO blood group region, plasma soluble E-selectin levels and risk of type 2 diabetes. Hum Mol Genet 2010;19:1856-62.
50. Barbalic M, Dupuis J, Dehghan A, et al. Large-scale genomic studies reveal central role of ABO in sP-selectin and sICAM-1 levels. Hum Mol Genet 2010;19:1863-72.
51. Lowenfels AB, Maisonneuve P, Cavallini G, et al. Pancreatitis and the risk of pancreatic cancer. Int Pancreatitis Study Group N Engl J Med 1993;328:1433-7.
52. Lowenfels AB, Maisonneuve P, Lankisch PG. Chronic pancreatitis and other risk factors for pancreatic cancer. Gastroenterol Clin North Am 1999;28:673-85, x.
53. Nishihara T, Koseki T. Microbial etiology of periodontitis. Periodontol 2000 2004;36:14-26.
54. Kinane DF, Hart TC. Genes and gene polymorphisms associated with periodontal disease. Crit Rev Oral Biol Med 2003;14:430-49.
55. Carvalho FM, Tinoco EM, Deeley K, et al. FAM5C contributes to aggressive periodontitis. PLoS One 2010;5:e10053.
56. Papapanou PN, Neiderud AM, Disick E, et al. Longitudinal stability of serum immunoglobulin G responses to periodontal bacteria. J Clin Periodontol 2004;31:985-90.